Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...

The condition mostly affects those from African and Caribbean backgrounds but Victoria Ekanoye says it can affect anyone. | ...

Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.

A study by the Centre for Policy Impact in Global Health revealed that over 30 per cent of people with SCD in Nigeria ...

Vertex Pharmaceuticals’ Casgevy (exagamglogene autotemcel) has continued to show benefits in sickle cell disease (SCD) ...

Sickle Cell Disease Market Insight, Epidemiology And Market Forecast - 2034The sickle cell disease treatment market is experiencing signific ...

Sickle cell disease affects about 100,000 people in the U.S., and 90% of patients are Black, according to NIH.

A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...

A doctor says she’s scrambling to figure out how she’ll continue her work helping sickle cell disease patients after the ...

By Deslyn a Joseph Patients afflicted with sickle cell disease gathered outside the Prime Minister's Office yesterday to ...

When Graham Serjeant arrived in Jamaica in 1966, it was accepted wisdom that few of those affected by sickle cell disease (SCD) survived beyond childhood. Yet he encountered adult patients living with ...